Cover Image
市場調查報告書

歐洲的醫藥品、醫療產業 (季度更新報告)

Europe Pharmaceuticals and Healthcare Report Q1 2017

出版商 BMI Research 商品編碼 363589
出版日期 內容資訊 英文 38 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的醫藥品、醫療產業 (季度更新報告) Europe Pharmaceuticals and Healthcare Report Q1 2017
出版日期: 2017年01月11日 內容資訊: 英文 38 Pages
簡介

本報告提供歐洲各國的製藥產業及醫療產業相關分析,地區整體產業規模的實際成果值、預測值 (過去5年、今後10年份) 估計,產業的課題 (風險) 和未來性的商機 (利潤) 相關評估,域內各地區的詳細趨勢,主要企業簡介等資訊彙整,為您概述為以下內容

BMI產業分析

  • 歐洲市場最新形勢

SWOT分析

  • 歐洲市場最新形勢

產業預測

  • 醫藥品市場最新形勢
  • 醫療市場最新形勢

產業的風險/利潤指標

  • 歐洲:風險/利潤指標

市場概況

  • 歐洲市場最新形勢

產業的趨勢與發展

  • 歐洲市場最新形勢

域內市場概況

  • 歐洲市場最新形勢

詞彙表

分析方法

  • 醫藥品支出額的預測模式
  • 醫療費的預測模式
  • 分析方法的相關註記
  • 風險/利潤指標技術
  • 指標概要
  • 指標的加權

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 2398-1024

BMI View: The growth outlook for pharmaceuticals and healthcare markets in Western and Emerging Europe are divergent. Ageing demographics will heighten demand throughout the region; however, it is the expansion of healthcare accessibility in emerging Europe that will be the primary driver of the sub-region's outperformance. Cost-containment measures will continue to repress growth. In Western Europe, these will manifest as increasingly aggressive pricing controls and stricter reimbursement levels, while in Emerging Europe, generic drug substitution policies will become more prominent.

Headline Expenditure Projections

  • Pharmaceuticals: USD319.0bn in 2015 to USD309.2bn in 2016; -3.1% in US dollar terms. Forecast revised upwards from last quarter.
  • Healthcare: USD1,850bn in 2015 to USD1,804bn in 2016; -2.5% in US dollar terms. Forecast revised downwards from last quarter.

Risk/Reward Index

In BMI's Q117 RRI, Europe scores 58.4 out of 100, comparing well with the Asia Pacific (51.2), the Americas (50.6), the Middle East and North Africa (48.1) and Sub Saharan Africa (32.5). The indicators used to assess the attractiveness of a pharmaceutical market are now visible, improving the transparency of the index system and enabling the identification of regional or group outperformers across single indicators. A market's RRI score is made up of a sum of the Rewards score (Industry Rewards + Country Rewards) and the Risks score (Industry Risks + Country Risks).

Table of Contents

BMI Industry View

  • Table: Headline Regional Pharmaceuticals & Healthcare Forecasts (2014-2020)

SWOT

Industry Forecast

  • Pharmaceutical Market Forecast
    • Table: Regional Pharmaceutical Sales, Historical Data & Forecasts (Europe (Region) 2012-2020)
  • Healthcare Market Forecast
    • Table: Regional Healthcare Expenditure Trends, Historical Data & Forecasts (Europe (Region) 2012-2020)

Industry Risk Reward Index

  • Europe Risk/Reward Index

Market Overview

Industry Trend Analysis

  • Regional Themes - Western Europe
  • Regional Themes - Central & Eastern Europe

Industry Trends & Developments

  • Regional Round-Up
    • Table: Europe Pharmaceutical Market (USDbn)

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
  • Index Overview
    • Table: Pharmaceutical Risk/Reward Index Indicators
  • Indicator Weightings
Back to Top